High Tech Pharm Co., Ltd. (KOSDAQ:106190)
13,490
+620 (4.82%)
At close: Feb 6, 2026
High Tech Pharm Revenue
High Tech Pharm had revenue of 17.87B KRW in the quarter ending September 30, 2025, with 5.60% growth. This brings the company's revenue in the last twelve months to 75.60B, down -7.30% year-over-year. In the year 2024, High Tech Pharm had annual revenue of 77.51B with 0.97% growth.
Revenue (ttm)
75.60B
Revenue Growth
-7.30%
P/S Ratio
1.90
Revenue / Employee
1.16B
Employees
65
Market Cap
143.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.51B | 740.98M | 0.97% |
| Dec 31, 2023 | 76.77B | -26.18B | -25.43% |
| Dec 31, 2022 | 102.95B | 29.66B | 40.47% |
| Dec 31, 2021 | 73.29B | -1.17B | -1.58% |
| Dec 31, 2020 | 74.46B | 11.39B | 18.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DongKoo Bio & Pharma | 238.39B |
| Kyung Dong Pharmaceutical | 193.64B |
| GREEN CROSS WellBeing | 151.06B |
| HYUNDAI BIOLAND | 129.68B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| KOREA PHARMA | 90.11B |
| OPTUS Pharmaceutical | 87.58B |
| Samik Pharmaceutical Company LTD. | 58.88B |